MCAT Biological and Biochemical Foundations of Living Systems Quiz: 1a Nonenzymatic Protein Function

What this quiz covers

This quiz focuses on 1a Nonenzymatic Protein Function, giving you a quick way to practice the rules, question types, and explanations that matter most for MCAT Biological and Biochemical Foundations of Living Systems.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. Scaffold S increases ligand concentration by secreting ligand into the synaptic cleft
2. Scaffold S stabilizes receptor positioning and coupling to signaling complexes, improving signal reliability (correct answer)
3. Scaffold S acts as the ligand and activates the receptor by binding its extracellular domain
4. Scaffold S catalyzes phosphorylation of the receptor tail, and deletion removes the catalytic site

Explanation: This question evaluates the nonenzymatic scaffolding function of intracellular proteins in organizing signaling complexes. Scaffold proteins like Scaffold S stabilize receptor positions and facilitate interactions without catalyzing reactions. In the neuronal model, deleting the binding motif disrupts Scaffold S's role in coupling the receptor to downstream signaling, reducing calcium transient reliability. Choice B is accurate as it describes how the scaffold improves signal consistency through structural organization. Choice D is misleading because it assumes catalytic activity in phosphorylation, which contradicts the nonenzymatic nature stated. To approach similar questions, note if ligand binding is unchanged to focus on post-binding organization. Verify by ensuring no enzymatic domains are mentioned, emphasizing structural roles.

Question 2

1. Mutant myoglobin binds O$_2$ less effectively, reducing intracellular O$_2$ buffering and diffusion toward mitochondria (correct answer)
2. Mutant myoglobin increases O$_2$ affinity, preventing O$_2$ release to mitochondria during contraction
3. Mutant myoglobin catalyzes O$_2$ production from water, compensating for reduced perfusion
4. Mutant myoglobin relocates to the extracellular matrix to transport O$_2$ in blood plasma

Explanation: This question assesses the nonenzymatic role of myoglobin in oxygen storage and facilitated diffusion in muscle cells. Myoglobin binds oxygen reversibly, acting as an intracellular buffer and transporter without enzymatic activity. In the skeletal muscle scenario, the mutant myoglobin's reduced affinity for O2 impairs its ability to hold and deliver oxygen to mitochondria during contractions. Choice A is correct because lower affinity decreases O2 buffering and diffusion, leading to earlier fatigue and intracellular O2 drops. Choice B is a distractor as it incorrectly suggests increased affinity would trap O2, but the mutation actually lowers affinity, not raises it. For similar problems, confirm if protein abundance is unchanged to isolate binding affinity effects. Always cross-check affinity changes with functional outcomes like delivery efficiency.

Question 3

1. The mAb acts as a receptor that transports viral proteins into the cell, and the mutations block transport
2. The mAb binds both strains equally, but only Strain 1 expresses enzymes needed for neutralization
3. The mAb binds Strain 2 more tightly, which explains the minimal ELISA signal due to faster dissociation
4. The mAb recognizes a conformational epitope whose altered residues in Strain 2 reduce complementarity and binding affinity (correct answer)

Explanation: This question assesses nonenzymatic antibody-antigen specificity via epitope complementarity. Monoclonal antibodies bind conformational epitopes, with mutations reducing affinity if complementarity decreases. The two-amino-acid difference weakens mAb binding to Strain 2, mirroring reduced neutralization. Choice D accurately ties this to altered epitope residues lowering affinity. Choice C reverses binding strength, misreading ELISA signals. For antibody assays, correlate binding with functional outcomes like neutralization. Verify by noting minimal signal indicates poor binding, not tighter.

Question 4

1. Loss of integrin–talin binding reduces linkage between extracellular matrix and actin cytoskeleton, weakening force transmission (correct answer)
2. Loss of integrin–talin binding increases fibronectin affinity, strengthening adhesion and traction
3. Talin normally catalyzes fibronectin crosslinking outside the cell, so tail mutation reduces fibronectin polymerization
4. Talin is a secreted ligand for integrins, so tail mutation should not affect adhesion strength

Explanation: This question assesses the nonenzymatic linking function of integrins in focal adhesions. Integrins connect extracellular matrix to cytoskeleton via talin without enzymatic activity. The tail mutation disrupts talin binding, weakening adhesion and force transmission despite normal fibronectin interaction. Choice A is correct as it describes impaired linkage reducing traction. Choice C incorrectly adds extracellular catalysis, but talin is intracellular. To verify, check if extracellular binding is preserved to isolate intracellular defects. Use force-related outcomes to confirm mechanical roles.

Question 5

1. Transporter G likely uses the Na$^+$ gradient to drive glucose uptake; removing Na$^+$ reduces cotransport-driven entry (correct answer)
2. Transporter G is a simple diffusion channel for glucose, so Na$^+$ removal should not affect uptake
3. Transporter G pumps Na$^+$ out of the cell while exporting glucose, so Na$^+$ removal should increase uptake
4. Transporter G catalyzes conversion of glucose into a fluorescent product, and Na$^+$ is a required substrate

Explanation: This question evaluates the nonenzymatic cotransport function of glucose transporters using ion gradients. Transporter G couples glucose uptake to Na+ influx, driven by the Na+ gradient without direct ATP use. Removing extracellular Na+ halts this secondary active transport, reducing uptake despite stable expression. Choice A is correct as it describes gradient-dependent cotransport. Choice B ignores the Na+ dependence, assuming passive diffusion. In uptake experiments, test ion substitutions to identify cotransporters. Confirm by noting unchanged expression isolates functional dependence.

Question 6

1. The receptor's main role is nuclear transport of viral proteins; extracellular binding is irrelevant to attachment
2. The receptor catalyzes viral genome replication at the membrane, and loss of the binding site blocks catalysis
3. The receptor is a soluble ligand secreted by the host cell; deleting the binding site increases viral binding
4. The receptor's extracellular domain provides a specific binding site required for viral attachment, enabling subsequent entry steps (correct answer)

Explanation: This question tests the nonenzymatic protein function of receptors in facilitating ligand binding, specifically in the context of viral attachment to host cells. Nonenzymatic protein functions include providing structural binding sites for ligands without catalyzing reactions, such as receptors that enable specific interactions between viruses and host cell surfaces. In this scenario, the host receptor's extracellular domain serves as a binding site for the viral surface protein, which is essential for viral attachment and subsequent entry into the cell. The correct answer, choice D, follows because the mutant receptor lacking the extracellular binding site shows reduced viral attachment despite normal membrane expression, indicating that the binding function is critical for entry without involvement in signaling during the short assay. A common distractor, such as choice B, is incorrect because it assumes an enzymatic role in catalyzing genome replication, which contradicts the lack of signaling defects and misattributes catalytic activity to a nonenzymatic binding function. To verify similar questions, always distinguish between enzymatic and nonenzymatic roles by checking if the protein's function involves catalysis or merely binding/support. Additionally, evaluate experimental outcomes like mutant effects to confirm the primary function, ensuring it aligns with observed deficits in attachment rather than unrelated processes.

Question 7

1. E-cadherin's primary role is to bind DNA in the nucleus to activate adhesion genes
2. E-cadherin catalyzes extracellular matrix degradation to allow cells to separate
3. E-cadherin functions as an ion pump that maintains polarity by exporting Na$^+$
4. E-cadherin mediates calcium-dependent cell-cell adhesion via homophilic extracellular interactions, promoting tissue cohesion (correct answer)

Explanation: This question tests the nonenzymatic adhesive function of cadherins in cell junctions. E-cadherin forms homophilic bonds extracellularly to maintain contacts, calcium-dependently, without catalysis. The domain mutation weakens binding, causing scattering despite intracellular preservation. Choice D correctly describes adhesion via homophilic interactions. Choice B wrongly assigns matrix degradation. In polarity assays, observe contact integrity post-mutation. Differentiate extra- vs. intracellular domains for function.

Question 8

1. The GPCR is a transporter that imports agonist; Antag blocks import, eliminating all responses at any agonist dose
2. The GPCR catalyzes agonist synthesis; Antag inhibits catalysis, lowering maximal response
3. Antag is the receptor and the GPCR is the ligand; competition shifts the curve by increasing receptor abundance
4. The GPCR binds agonist to initiate signaling; Antag reduces apparent agonist potency by competing for the binding site (correct answer)

Explanation: This question evaluates nonenzymatic ligand binding in GPCR signaling. GPCRs bind agonists to activate pathways; competitive antagonists occupy sites, shifting dose-responses rightward without max change. Antag competes without response, consistent with nonenzymatic binding competition. Choice D is correct as it describes site competition reducing potency. Choice B wrongly adds catalysis to the GPCR. In pharmacology, analyze curve shifts for competitive vs. noncompetitive. Verify max response to distinguish antagonism types.

Question 9

1. Increased microtubule polymerization in cilia due to direct activation of tubulin by F-actin
2. Reduced mechanical support for the apical cortex, limiting effective transmission of ciliary forces to the mucus layer (correct answer)
3. Decreased hydrolysis of ATP by actin, reducing energy available for ciliary beating
4. Enhanced secretion of mucins from the nucleus due to actin-mediated transcriptional catalysis

Explanation: This question tests the nonenzymatic function of actin filaments in providing mechanical support within cellular structures. F-actin, the polymerized form of actin, contributes to cytoskeletal integrity and force transmission without catalyzing reactions. In this airway epithelium model, Drug X binds F-actin, likely disrupting its structural role in the apical cortex that supports ciliary movement. The reduced bead transport and ciliary beat amplitude, despite unchanged ATP levels, align with choice B, as weakened mechanical support impairs the transmission of ciliary forces to the mucus layer. A common distractor like choice C is incorrect because it misattributes ATP hydrolysis to actin itself, confusing actin's nonenzymatic role with myosin's enzymatic activity in contraction. To verify similar questions, assess whether outcomes stem from structural disruption rather than energy depletion. A useful strategy is to check if ATP levels are mentioned as unchanged, pointing toward nonenzymatic mechanical functions over catalytic ones.

Question 10

1. Microtubules function as membrane channels that allow vesicles to pass through the plasma membrane
2. Microtubules directly synthesize ATP needed for vesicle transport, and destabilization lowers ATP production
3. Microtubules provide polarized tracks that support directed vesicle transport; destabilization disrupts long-range delivery (correct answer)
4. Microtubules inhibit vesicle movement by binding vesicles nonspecifically, so destabilization should increase directed transport

Explanation: This question tests the nonenzymatic function of microtubules as tracks for intracellular transport. Microtubules provide polarized scaffolds for motor-driven vesicle movement without catalytic roles. Destabilizing microtubules shifts vesicle transport from directed to diffusive, with pauses, despite normal ATP and actin. Choice C correctly identifies this track disruption impairing long-range delivery. Choice B wrongly assigns ATP synthesis to microtubules, confusing them with mitochondria. In similar experiments, observe movement patterns to distinguish directed vs. random motion. Verify by confirming unaffected components like ATP to isolate structural effects.

Question 11

1. Hormone increases apical water permeability primarily by redistributing existing channels to the membrane via motif-dependent trafficking (correct answer)
2. Hormone increases water permeability by inducing de novo synthesis of Channel W and inserting it into mitochondria
3. Channel W catalyzes conversion of solutes into water, raising permeability without membrane insertion
4. The trafficking motif prevents Channel W from reaching the apical surface, so deleting it should enhance apical accumulation

Explanation: This question evaluates the nonenzymatic role of trafficking motifs in directing protein localization. Channel W, as an aquaporin, facilitates water passage but relies on motifs for hormone-induced membrane insertion without synthesis. The hormone triggers vesicle trafficking to increase apical Channel W, enhancing permeability over 30 minutes. Choice A accurately describes this redistribution mechanism dependent on the motif. Choice D is incorrect as it suggests the motif inhibits trafficking, but deletion prevents accumulation. For comparable scenarios, note short timescales ruling out synthesis. Check if total protein is unchanged to emphasize trafficking over expression.

Question 12

1. The adaptor-binding motif is required for extracellular ligand binding, so loss of the motif should reduce radioligand binding.
2. AD likely binds the cytoplasmic tail of ligand-bound R to organize signaling complexes; loss of this binding impairs receptor clustering and calcium responses. (correct answer)
3. AD likely serves as the neurotransmitter ligand for R, so removing the motif should increase calcium transients due to reduced ligand sequestration.
4. AD likely transports the neurotransmitter across the membrane through R, so loss of the motif should abolish ligand binding and increase synaptic clustering.

Explanation: This question examines the nonenzymatic role of cytoplasmic adaptor proteins in organizing receptor signaling complexes at synapses. The adaptor protein AD binds to the receptor's cytoplasmic tail after ligand binding, serving as a scaffold to recruit other signaling proteins and promote receptor clustering without any catalytic activity. The key observation is that removing the adaptor-binding motif doesn't affect ligand binding (extracellular function intact) but severely impairs receptor clustering and downstream calcium signaling (intracellular organization disrupted). The correct answer (B) accurately describes AD's role in binding the ligand-occupied receptor's tail to organize signaling complexes and promote synaptic clustering. Incorrect options misidentify AD as the extracellular ligand (C), a transporter (D), or suggest the motif is required for ligand binding (A), contradicting the experimental data. When analyzing receptor-adaptor interactions, distinguish between extracellular ligand binding (unaffected by cytoplasmic mutations) and intracellular signaling organization (dependent on adaptor recruitment), and remember that adaptors function through protein-protein interactions rather than enzymatic activities.

Question 13

1. The mutation should increase uptake at low apical glucose because weaker binding accelerates transport cycling.
2. The mutation should reduce uptake at low apical glucose but be partially overcome at high apical glucose due to mass action increasing transporter occupancy. (correct answer)
3. The mutation should reverse transport direction so glucose is pumped out of the cell against its gradient.
4. The mutation should primarily decrease ATP production because GT directly catalyzes glycolysis once glucose binds.

Explanation: This question tests understanding of facilitative transporters and how binding affinity affects transport kinetics without enzymatic catalysis. Glucose transporters like GT bind glucose and undergo conformational changes to move it across membranes following concentration gradients, functioning through reversible ligand binding rather than active transport. The mutation increases Kd (decreases affinity), meaning GT binds glucose less tightly, which reduces transport efficiency at low glucose concentrations where transporter occupancy is limited. The correct answer (B) explains that at high glucose concentrations, mass action increases the probability of glucose binding despite lower affinity, partially compensating for the reduced binding strength and allowing transport to approach control levels. Option A incorrectly suggests weaker binding increases transport, while C proposes impossible gradient reversal for a facilitative transporter, and D assigns an enzymatic role GT doesn't possess. When analyzing transporter mutations, consider how binding affinity affects the relationship between substrate concentration and transport rate, remembering that facilitative transporters can only move substances down concentration gradients and that high substrate concentrations can partially overcome reduced binding affinity.

Question 14

1. SP primarily catalyzes CC folding in the endoplasmic reticulum, so SP knockout should reduce total CC protein abundance.
2. SP promotes apical retention/localization of CC by linking CC to cortical actin, so loss of actin binding reduces CC surface stability without changing total CC levels. (correct answer)
3. SP serves as the extracellular ligand for CC, so SP knockout should increase CC surface levels due to reduced receptor internalization.
4. SP is a nuclear transcription factor for the CC gene, so SP knockout should decrease CC mRNA and therefore decrease total CC protein.

Explanation: This question tests understanding of nonenzymatic scaffolding proteins that organize membrane protein complexes through protein-protein interactions. Scaffolding proteins like SP serve as molecular organizers that link transmembrane proteins to the cytoskeleton, stabilizing their localization at specific membrane domains without catalyzing any chemical reactions. In this scenario, SP binds both the chloride channel (CC) and cortical actin, creating a physical bridge that anchors CC at the apical membrane. The correct answer (B) is supported by the observation that total CC protein remains unchanged while surface CC decreases, indicating SP affects localization rather than synthesis or degradation. Common distractors incorrectly assign enzymatic roles (A), ligand functions (C), or transcriptional activities (D) to SP, when the data clearly shows SP functions through direct protein-protein interactions. When analyzing scaffolding proteins, look for evidence of unchanged total protein levels with altered subcellular localization, and remember that scaffolds organize complexes through binding interactions rather than catalytic activities.

Question 15

1. Competitor S increases nuclear fluorescence because it stabilizes the R–S* complex once it reaches the nucleus
2. Competitor S decreases nuclear fluorescence because it occupies the same binding site on R as S* (correct answer)
3. Competitor S has no effect on nuclear fluorescence because intracellular receptors bind ligands only after nuclear import
4. Competitor S decreases nuclear fluorescence because it inhibits enzymatic conversion of S* into a membrane-permeable form

Explanation: This question tests understanding of competitive binding in nonenzymatic protein-ligand interactions, specifically how intracellular receptors function as specific binding proteins. The core concept is that specific ligand-binding proteins have defined binding sites that can be occupied by structurally similar molecules, leading to competition. In this scenario, the unlabeled competitor steroid S can occupy the same binding site on receptor R as the fluorescent steroid S*, preventing S* from binding and subsequently translocating to the nucleus. The correct answer B follows because pretreatment with competitor S will reduce the amount of R-S* complex formation and thus decrease nuclear fluorescence. Choice C is incorrect because it reflects a misconception that intracellular receptors cannot bind ligands in the cytoplasm - in reality, steroid receptors typically bind their ligands in the cytoplasm before translocating to the nucleus. A key strategy for similar questions is to recognize that competitive inhibition demonstrates specific binding through shared binding sites.

Question 16

1. Reduced binding of TBP to microtubules, preventing nuclear entry and selectively affecting TATA promoters
2. Increased binding of TBP to ribosomal RNA, reducing translation and indirectly lowering reporter signal
3. Enhanced catalytic methylation of promoter DNA by TBP, silencing TATA-containing genes
4. Reduced binding of TBP to promoter DNA, impairing assembly of the preinitiation complex at TATA-containing genes (correct answer)

Explanation: This question tests understanding of transcription factors as nonenzymatic DNA-binding proteins that recruit other proteins to regulate gene expression. TATA-binding protein (TBP) recognizes and binds the TATA box sequence in gene promoters through shape complementarity and electrostatic interactions, bending the DNA and serving as a platform for recruiting other transcription factors to form the preinitiation complex. The mutant with reduced TATA box affinity cannot effectively bind TATA-containing promoters, preventing proper preinitiation complex assembly and reducing basal transcription from these genes while minimally affecting TATA-less promoters that use different core promoter elements. This demonstrates TBP's role as a sequence-specific DNA-binding protein rather than an enzyme. Choice C incorrectly suggests TBP catalyzes DNA methylation, but TBP functions through noncovalent DNA binding and protein recruitment, not chemical modification. To analyze transcription factor function, focus on how they recognize specific DNA sequences and recruit other proteins through binding interactions rather than enzymatic activities.

Question 17

1. Stronger covalent bonding between heme iron and O$_2$, decreasing O$_2$ release to tissues
2. Reduced noncovalent stabilization of bound O$_2$ within the heme pocket, lowering O$_2$ affinity (correct answer)
3. Increased catalytic conversion of O$_2$ to reactive oxygen species, raising $P_{50}$ indirectly
4. Enhanced binding of hemoglobin to actin filaments, shifting the equilibrium toward O$_2$ unloading

Explanation: This question tests understanding of hemoglobin's nonenzymatic oxygen-binding function and how protein structure affects ligand affinity. Hemoglobin binds oxygen through noncovalent interactions between the heme iron and O₂, with surrounding amino acids in the heme pocket providing additional stabilization through hydrogen bonds and hydrophobic interactions. A higher P₅₀ (right-shifted curve) indicates decreased oxygen affinity, meaning the protein releases oxygen more readily at a given partial pressure. The amino acid substitution in the heme pocket likely disrupts the noncovalent stabilization of bound oxygen, making it easier for O₂ to dissociate from the heme group. Choice A incorrectly describes covalent bonding between heme and oxygen, but oxygen binding to hemoglobin is reversible and noncovalent. When analyzing protein variants, consider how structural changes affect the stability of protein-ligand complexes through altered noncovalent interactions rather than assuming enzymatic or covalent modifications.

Question 18

1. Improved resistance to stretch because weaker integrin–ECM binding increases focal adhesion stability
2. Reduced force transmission from ECM to cytoskeleton because integrin normally provides a mechanical linkage (correct answer)
3. Unchanged adhesion because integrins act only as soluble oxygen carriers in the cytosol
4. Enhanced actin polymerization because integrins catalyze ATP hydrolysis required for filament growth

Explanation: This question tests understanding of integrins as nonenzymatic proteins that mechanically link the extracellular matrix to the intracellular cytoskeleton. Integrins are transmembrane receptors that bind ECM proteins like fibronectin extracellularly while connecting to actin filaments intracellularly through adaptor proteins, creating focal adhesions that transmit mechanical forces. The mutation reducing fibronectin binding weakens the mechanical linkage between ECM and cytoskeleton, preventing proper force transmission during cyclic stretch and causing stress fiber disruption and cell detachment. This demonstrates integrin's structural role in mechanotransduction rather than any enzymatic function. Choice D incorrectly suggests integrins catalyze ATP hydrolysis for actin polymerization, but integrins function as mechanical linkers, not enzymes. When analyzing adhesion receptor function, consider how they create physical connections between cellular compartments to transmit forces or signals, rather than assuming catalytic activities.

Question 19

1. The variant increases LDL uptake because loss of the NPXY motif enhances clathrin recruitment
2. The variant binds LDL but fails to internalize efficiently because the cytosolic motif mediates adaptor protein interactions for endocytosis (correct answer)
3. The variant cannot bind LDL because cytosolic motifs determine extracellular ligand specificity
4. Wild-type LDLR accumulates LDL in endosomes by catalyzing LDL degradation at the plasma membrane

Explanation: This question tests understanding of receptor-mediated endocytosis and the nonenzymatic role of cytosolic motifs in protein trafficking. The LDL receptor binds LDL particles at the cell surface through its extracellular domain, but internalization requires the cytosolic NPXY motif to recruit adaptor proteins like AP-2 that link the receptor to clathrin-coated pit formation. The variant lacking this motif can still bind LDL (demonstrating intact extracellular function) but cannot efficiently internalize because it fails to interact with the endocytic machinery, preventing LDL accumulation in endosomes. This shows how protein trafficking depends on specific protein-protein interactions mediated by recognition motifs. Choice C incorrectly suggests cytosolic sequences determine extracellular ligand binding, but ligand specificity is determined by the extracellular domain structure. When analyzing receptor trafficking, distinguish between ligand binding (extracellular) and internalization signals (cytosolic), recognizing that both are nonenzymatic protein-protein interactions.

Question 20

1. The RTK primarily acts as a cytosolic oxygen carrier; deleting the extracellular domain prevents oxygen binding and reduces phosphorylation
2. The RTK requires extracellular ligand binding to initiate receptor activation; deleting the binding domain prevents signal initiation at the membrane (correct answer)
3. Deleting the extracellular domain increases signaling because ligand binding normally inhibits RTK activation
4. The RTK signals by catalyzing glycolysis at the cell surface; deleting the extracellular domain reduces ATP production and phosphorylation

Explanation: This question tests understanding of receptor tyrosine kinases and how their nonenzymatic ligand-binding function initiates enzymatic signaling cascades. RTKs have an extracellular ligand-binding domain that, upon growth factor binding, induces receptor dimerization and brings the intracellular kinase domains into proximity for trans-autophosphorylation. The variant lacking the extracellular domain cannot bind growth factor and therefore cannot undergo ligand-induced dimerization, preventing kinase activation and downstream phosphorylation events despite proper membrane localization. This demonstrates how the nonenzymatic ligand-binding event is essential for initiating the enzymatic cascade. Choice C incorrectly suggests ligand binding inhibits RTK activation, but growth factor binding is the activating event for RTKs. When analyzing receptor signaling, recognize that extracellular ligand binding (nonenzymatic) triggers conformational changes that enable intracellular enzymatic activity, showing how nonenzymatic and enzymatic functions are coupled in signaling proteins.